rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Bartie Wendy Short

EVP, Corporate Affairs

Company insider

Files Form 4 as: EVP, Corporate Affairs, Bristol-Myers Squibb.

Every Form 4 they filed

In numbers

Trades disclosed
49
Buys
0
Sells
1
Bought
$0
Sold
$17K
Companies
1
Companies where not an officer
0
First trade
3 Jun 2025
Last trade
1 Sep 2026
Last filed
3 Sep 2026

Companies traded

Where they are an officer
BMY Bristol-Myers SquibbOfficer · Pharmaceuticals · last 1 Sep 20260 buys · 1 sell

Activity over time

1 Jul 2025 – 1 Oct 2026
10Jul 25Nov 25Mar 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M$83K1,236 at $66.92filing
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$42K633 at $66.92filing
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,236 at $0.00filing
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,236 at $0.00filing
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M$83K1,236 at $66.92filing
1 Sep 2026filed 3 Sep 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$42K633 at $66.92filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—8,040 at $0.00filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$212K3,876 at $54.72filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—8,040 at $0.00filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—8,040 at $0.00filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—8,040 at $0.00filing
3 Jun 2026filed 5 Jun 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$212K3,876 at $54.72filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code M—639 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—639 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—749 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,495 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—6,531 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers Squibboption or derivative · PharmaceuticalsSEC FORM 4 Code A—9,796 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code J—72 at $0.00filing
10 Mar 2026filed 12 Mar 2026BMY Bristol-Myers SquibbPharmaceuticalsSEC FORM 4 Code F$12K205 at $60.13filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Cari GallmanEVP, General Counsel · EVP, General Counsel at Bristol Myers Squibb Co, filing Form 4 there in the last year
Theodore R. Samuels IIDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Peter J. ArduiniDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Derica W. RiceDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Phyllis R. YaleDirector · Director at Bristol Myers Squibb Co, filing Form 4 there in the last year
Cristian MassacesiEVP,Chief Med Offr,Head of Dev · Also traded BMY in the last 90 days
Phil M. HolzerSVP and Controller · Also traded BMY in the last 90 days